Sima Rafati

Sima Rafati

UNVERIFIED PROFILE

Are you Sima Rafati?   Register this Author

Register author
Sima Rafati

Sima Rafati

Publications by authors named "Sima Rafati"

Are you Sima Rafati?   Register this Author

99Publications

1507Reads

40Profile Views

Visualization of Leishmania tropica Infection in BALB/c Mice by Bioluminescence Imaging

Iran Biomed J 2020 05 1;24(3):164-72. Epub 2019 Dec 1.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275622PMC
May 2020

The outcome of arginase activity inhibition in BALB/c mice hosting Leishmania tropica.

Parasite Immunol 2020 03 7;42(3):e12691. Epub 2020 Jan 7.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pim.12691DOI Listing
March 2020

Profiling inflammatory response in lesions of cutaneous leishmaniasis patients using a non-invasive sampling method combined with a high-throughput protein detection assay.

Cytokine 2020 Mar 17;130:155056. Epub 2020 Mar 17.

Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Sweden; Vaccine Evaluation Center, BC Children's Hospital Research Institute, The University of British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cyto.2020.155056DOI Listing
March 2020

Comparative study of different forms of Jellein antimicrobial peptide on Leishmania parasite.

Exp Parasitol 2020 Feb 17;209:107823. Epub 2019 Dec 17.

Immunotherapy and Leishmania Vaccine Research Department, Pasteur Institute of Iran, Tehran, Iran. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exppara.2019.107823DOI Listing
February 2020

Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice.

PLoS Negl Trop Dis 2020 01 3;14(1):e0007939. Epub 2020 Jan 3.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0007939DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941807PMC
January 2020

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis.

Int J Parasitol Drugs Drug Resist 2019 12 23;11:156-165. Epub 2019 Sep 23.

Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijpddr.2019.09.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904837PMC
December 2019

Antileishmanial effect of rapamycin as an alternative approach to control Leishmania tropica infection.

Vet Parasitol 2019 Dec 10;276:108976. Epub 2019 Nov 10.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vetpar.2019.108976DOI Listing
December 2019

Translating Observations From Leishmanization Into Non-Living Vaccines: The Potential of Dendritic Cell-Based Vaccination Strategies Against .

Front Immunol 2018 4;9:1227. Epub 2018 Jun 4.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2018.01227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996938PMC
August 2019

Biomarkers of Cutaneous Leishmaniasis.

Front Cell Infect Microbiol 2018 26;8:222. Epub 2018 Jun 26.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fcimb.2018.00222DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029629PMC
July 2019

A non-pathogenic Leishmania tarentolae vector based- HCV polytope DNA vaccine elicits potent and long lasting Th1 and CTL responses in BALB/c mice model.

Mol Immunol 2019 07 1;111:152-161. Epub 2019 May 1.

Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2019.04.009DOI Listing
July 2019

Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials.

PLoS Negl Trop Dis 2019 02 27;13(2):e0007217. Epub 2019 Feb 27.

Immunotherapy and Leishmania Vaccine Research Department, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0007217DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411200PMC
February 2019

Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin.

PLoS Negl Trop Dis 2018 08 22;12(8):e0006701. Epub 2018 Aug 22.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0006701DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122837PMC
August 2018

Study Break: Possible Diagnostic Improvement for Cutaneous Leishmaniasis: Is It Achievable?

Iran Biomed J 2018 Jul 27;22(4):215-6. Epub 2018 Feb 27.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949123PMC
July 2018

Prospects for antimicrobial peptide-based immunotherapy approaches in Leishmania control.

Expert Rev Anti Infect Ther 2018 06 12;16(6):461-469. Epub 2018 Jun 12.

a Department of Immunotherapy and Leishmania Vaccine Research , Pasteur Institute of Iran , Tehran , Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14787210.2018.1483720DOI Listing
June 2018

Leishmania tropica infected human lesions: Whole genome transcription profiling.

Acta Trop 2017 Dec 24;176:236-241. Epub 2017 Aug 24.

Immunotherpy and Leishmania Vaccine Research Dept., Pasteur Institute of Iran, Tehran, Iran. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.actatropica.2017.08.016DOI Listing
December 2017

Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice.

PLoS Negl Trop Dis 2017 12 18;11(12):e0006123. Epub 2017 Dec 18.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0006123DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749894PMC
December 2017

Live Leishmania tarentolae secreting HNP1 as an immunotherapeutic tool against Leishmania infection in BALB/c mice.

Immunotherapy 2017 10;9(13):1089-1102

Department of Immunotherapy & Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran, 13194.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2017-0076DOI Listing
October 2017

A novel non-invasive diagnostic sampling technique for cutaneous leishmaniasis.

PLoS Negl Trop Dis 2017 Jul 13;11(7):e0005750. Epub 2017 Jul 13.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0005750DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526608PMC
July 2017

Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites.

PLoS Negl Trop Dis 2017 Jul 14;11(7):e0005774. Epub 2017 Jul 14.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0005774DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529023PMC
July 2017

Protein/Protein, DNA/DNA and DNA/Protein based vaccination strategies using truncated Omp2b against Brucella infection in BALB/c Mice.

Int J Med Microbiol 2017 Jun 28;307(4-5):249-256. Epub 2017 Mar 28.

Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijmm.2017.03.004DOI Listing
June 2017

PUF Proteins: Cellular Functions and Potential Applications.

Curr Protein Pept Sci 2017 ;18(3):250-261

Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389203717666160914172908DOI Listing
May 2017

Old World cutaneous leishmaniasis challenges in Morocco, Algeria, Tunisia and Iran (MATI): a collaborative attempt to combat the disease.

Expert Rev Vaccines 2017 May 10;16(5):415-417. Epub 2017 Apr 10.

c Department of Immunotherapy and Leishmania Vaccine Research , Pasteur Institute of Iran , Tehran , Iran.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14760584.2017.1
Publisher Site
http://dx.doi.org/10.1080/14760584.2017.1311792DOI Listing
May 2017

Optimization of the Timing of Induction for the Assessment of Nitric Oxide Production in Infected Macrophage Cells.

Iran J Parasitol 2016 Jul-Sep;11(3):325-331

Dept. of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256048PMC
January 2017

DNA Integration in Leishmania Genome: An Application for Vaccine Development and Drug Screening.

Methods Mol Biol 2016 ;1403:603-22

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-3387-7_34DOI Listing
December 2016

Comparison of potential protection conferred by three immunization strategies (protein/protein, DNA/DNA, and DNA/protein) against Brucella infection using Omp2b in BALB/c Mice.

Vet Microbiol 2016 Dec 5;197:47-52. Epub 2016 Nov 5.

Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vetmic.2016.10.027DOI Listing
December 2016

Mammalian host defense peptides and their implication on combating Leishmania infection.

Cell Immunol 2016 11 4;309:23-31. Epub 2016 Oct 4.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellimm.2016.10.001DOI Listing
November 2016

Drug Targeting to Macrophages With Solid Lipid Nanoparticles Harboring Paromomycin: an In Vitro Evaluation Against L. major and L. tropica.

AAPS PharmSciTech 2016 Oct 9;17(5):1110-9. Epub 2015 Nov 9.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1208/s12249-015-0439-1
Publisher Site
http://dx.doi.org/10.1208/s12249-015-0439-1DOI Listing
October 2016

T Helper 1 (Th1), Th2, and Th17 Responses to Leishmania major Lipophosphoglycan 3.

Immunol Invest 2016 Oct 9;45(7):692-702. Epub 2016 Sep 9.

b Drug Applied Research Center , Tabriz University of Medical Sciences , Tabriz , Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08820139.2016.1208217DOI Listing
October 2016

Leishmania-based expression systems.

Appl Microbiol Biotechnol 2016 Sep 20;100(17):7377-85. Epub 2016 Jul 20.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Pasteur Ave. No. 69, Tehran, 13164, Iran.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00253-016-7712-4
Publisher Site
http://dx.doi.org/10.1007/s00253-016-7712-4DOI Listing
September 2016

Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model.

Appl Microbiol Biotechnol 2016 Aug 10;100(16):7051-60. Epub 2016 Mar 10.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00253-016-7422-yDOI Listing
August 2016

Delivery systems for Leishmania vaccine development.

Expert Rev Vaccines 2016 07 28;15(7):879-95. Epub 2016 Mar 28.

a Department of Immunotherapy and Leishmania Vaccine Research , Pasteur Institute of Iran , Tehran , Iran (the Islamic Republic of).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14760584.2016.1157478DOI Listing
July 2016

EGFP reporter protein: its immunogenicity in Leishmania-infected BALB/c mice.

Appl Microbiol Biotechnol 2016 May 19;100(9):3923-34. Epub 2015 Dec 19.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00253-015-7201-1DOI Listing
May 2016

Post-Genomics and Vaccine Improvement for Leishmania.

Front Microbiol 2016 6;7:467. Epub 2016 Apr 6.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmicb.2016.00467DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822237PMC
April 2016

Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy.

J Breast Cancer 2016 Mar 25;19(1):34-44. Epub 2016 Mar 25.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4048/jbc.2016.19.1.34DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822105PMC
March 2016

Recombinant LPG3 Stimulates IFN-Γ and TNF-A Secretion by Human NK Cells.

Iran J Parasitol 2015 Oct-Dec;10(4):554-60

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Dept. of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724831PMC
January 2016

Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4+ T cells.

Sci Transl Med 2015 Oct;7(310):310ra167

Department of Immunology, College of Medicine, University of Manitoba, Winnipeg, Manitoba R3T 0T5, Canada. Department of Medical Microbiology, College of Medicine, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.aac5477DOI Listing
October 2015

Immunological comparison of DNA vaccination using two delivery systems against canine leishmaniasis.

Vet Parasitol 2015 Sep 21;212(3-4):130-9. Epub 2015 Jul 21.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, 69, Pasteur Ave., Tehran 13164, Iran. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vetpar.2015.07.005DOI Listing
September 2015

Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.

Mol Immunol 2015 Aug 18;66(2):384-91. Epub 2015 May 18.

Department of Molecular Biology, Pasteur Institute of Iran, Pasteur Street, Tehran, Iran. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2015.04.015DOI Listing
August 2015

Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice.

Mol Immunol 2015 Jun 24;65(2):287-92. Epub 2015 Feb 24.

Department of Molecular Biology, Pasteur Institute of Iran, Pasteur Street, Tehran, Iran. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2015.01.009DOI Listing
June 2015

Generation of stable L. major(+EGFP-LUC) and simultaneous comparison between EGFP and luciferase sensitivity.

Exp Parasitol 2015 Mar 28;150:44-55. Epub 2015 Jan 28.

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00144894150001
Publisher Site
http://dx.doi.org/10.1016/j.exppara.2015.01.008DOI Listing
March 2015

IL2RA genetic variants reduce IL-2-dependent responses and aggravate human cutaneous leishmaniasis.

J Immunol 2015 Mar 11;194(6):2664-72. Epub 2015 Feb 11.

Aix Marseille Université, Génétique et Immunologie des Maladies Parasitaires, Unité Mixte de Recherche S906, 13385 Marseille, France; INSERM, Unité 906, 13385 Marseille, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1402047DOI Listing
March 2015

Enhancement of HCV polytope DNA vaccine efficacy by fusion to an N-terminal fragment of heat shock protein gp96.

Arch Virol 2015 Jan 28;160(1):141-52. Epub 2014 Oct 28.

Department of Virology, School of Public Health, Tehran University of Medical Sciences, P.O.Box 6446, Tehran, 14155, Islamic Republic of Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00705-014-2243-8DOI Listing
January 2015

In Vitro Evaluation of Influenza M2 and Leishmania major HSP70 (221-604) Chimer Protein.

Jundishapur J Microbiol 2014 Sep 1;7(9):e11812. Epub 2014 Sep 1.

Influenza Research Lab, Department of Virology, Pasteur Institute of Iran, Tehran, IR Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5812/jjm.11812DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255373PMC
September 2014

Live vaccination tactics: possible approaches for controlling visceral leishmaniasis.

Front Immunol 2014 31;5:134. Epub 2014 Mar 31.

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran , Tehran , Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2014.00134DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978289PMC
June 2014

Immunomodulatory effects of IP-10 chemokine along with PEI600-Tat delivery system in DNA vaccination against HPV infections.

Mol Immunol 2013 Jan 25;53(1-2):149-60. Epub 2012 Aug 25.

Molecular Immunology and Vaccine Research Lab., Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2012.07.011DOI Listing
January 2013

Mini-chaperones: potential immuno-stimulators in vaccine design.

Hum Vaccin Immunother 2013 Jan 29;9(1):153-61. Epub 2012 Oct 29.

Molecular Immunology and Vaccine Research Lab., Pasteur Institute of Iran, Tehran, Iran. azam_bolhassani@yahoo

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/hv.22248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667931PMC
January 2013

Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.

Immunol Lett 2012 Dec 17;148(2):117-25. Epub 2012 Oct 17.

Molecular Immunology and Vaccine Research Lab., Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016524781200215
Publisher Site
http://dx.doi.org/10.1016/j.imlet.2012.10.003DOI Listing
December 2012

Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.

Immunotherapy 2012 Nov;4(11):1107-20

Molecular Immunology & Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.12.110DOI Listing
November 2012

CD8(+) T cells in leishmania infections: friends or foes?

Front Immunol 2012 24;3. Epub 2012 Jan 24.

Institut National de la Recherche Scientifique, Institut Armand Frappier, Université du Québec Laval, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2012.00005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342007PMC
August 2012

Chemokine-based immunotherapy: delivery systems and combination therapies.

Immunotherapy 2012 Aug;4(8):807-40

Molecular Immunology & Vaccine Research Lab, Pasteur Institute of Iran, Tehran 13164, Iran.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/imt.12.72
Publisher Site
http://dx.doi.org/10.2217/imt.12.72DOI Listing
August 2012

Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems.

Expert Rev Vaccines 2012 Jan;11(1):69-86

Quality Control Department, Research and Production Complex, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erv.11.166DOI Listing
January 2012

Effect of A2 gene on infectivity of the nonpathogenic parasite Leishmania tarentolae.

Parasitol Res 2011 Sep 26;109(3):793-9. Epub 2011 Mar 26.

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00436-011-2325-4DOI Listing
September 2011

Leishmaniasis: Middle East and North Africa research and development priorities.

PLoS Negl Trop Dis 2011 Jul 26;5(7):e1219. Epub 2011 Jul 26.

Eck Institute for Global Health, Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0001219DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144177PMC
July 2011

Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice model.

Exp Parasitol 2011 May 26;128(1):9-17. Epub 2011 Jan 26.

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, 69 Pasteur Ave., Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exppara.2011.01.012DOI Listing
May 2011

Immunogenicity of a plant-derived edible chimeric EspA, Intimin and Tir of Escherichia coli O157:H7 in mice.

Plant Sci 2011 Apr 15;180(4):620-7. Epub 2011 Jan 15.

Department of Plant Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.plantsci.2011.01.004DOI Listing
April 2011

Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasis.

Exp Parasitol 2011 Mar 25;127(3):627-36. Epub 2010 Dec 25.

Molecular Immunology and Vaccine Research Lab, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exppara.2010.12.007DOI Listing
March 2011

Improvement of different vaccine delivery systems for cancer therapy.

Mol Cancer 2011 Jan 7;10. Epub 2011 Jan 7.

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1186%2F1476-4598-10-
Web Search
http://molecular-cancer.biomedcentral.com/articles/10.1186/1
Publisher Site
http://dx.doi.org/10.1186/1476-4598-10-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024302PMC
January 2011

Leishmania major: disruption of signal peptidase type I and its consequences on survival, growth and infectivity.

Exp Parasitol 2010 Oct 22;126(2):135-45. Epub 2010 Apr 22.

Molecular Immunology and Vaccine Research Lab, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exppara.2010.04.009DOI Listing
October 2010

Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157:H7.

Vaccine 2010 Oct 13;28(42):6923-9. Epub 2010 Aug 13.

Applied Biotechnology Research Center, Baqiyatallah Medical Science University, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2010.07.061DOI Listing
October 2010

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.

Vaccine 2009 Dec 8;28(1):53-62. Epub 2009 Oct 8.

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2009.09.114DOI Listing
December 2009

In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applications.

Theor Biol Med Model 2009 Dec 8;6:28. Epub 2009 Dec 8.

National Institute of Genetic Engineering and Biotechnology, Shahrak-e- Pajoohesh, 15th Km, Tehran -Karaj Highway, Tehran, IR, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1742-4682-6-28DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224939PMC
December 2009

Antibody detection against HPV16 E7 & GP96 fragments as biomarkers in cervical cancer patients.

Indian J Med Res 2009 Nov;130(5):533-41

Molecular Immunology & Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
November 2009

Different spectra of therapeutic vaccine development against HPV infections.

Hum Vaccin 2009 Oct 28;5(10):671-89. Epub 2009 Oct 28.

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/hv.5.10.9370DOI Listing
October 2009

Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals.

Vaccine 2008 Oct 18;26(46):5822-9. Epub 2008 Sep 18.

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2008.08.065DOI Listing
October 2008

Heat-shock proteins as powerful weapons in vaccine development.

Expert Rev Vaccines 2008 Oct;7(8):1185-99

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14760584.7.8.1185DOI Listing
October 2008

Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies.

Vaccine 2008 Jun 18;26(26):3362-70. Epub 2008 Apr 18.

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2008.03.082DOI Listing
June 2008

Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice.

Exp Parasitol 2008 Mar 13;118(3):393-401. Epub 2007 Oct 13.

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exppara.2007.10.004DOI Listing
March 2008

Innate immune system: specific or non-specific?

Med Hypotheses 2007 7;69(2):460-1. Epub 2007 May 7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mehy.2007.01.003DOI Listing
August 2007

The dense granule protein GRA2, a new marker for the serodiagnosis of acute Toxoplasma infection: comparison of sera collected in both France and Iran from pregnant women.

Diagn Microbiol Infect Dis 2007 Aug 16;58(4):419-26. Epub 2007 May 16.

CNRS UMR 5163, UFR de Biologie, Institut Jean Roget, Université Joseph Fourier, Campus Santé, Domaine de la Merci, and Parasitology and Mycology Laboratory, Grenoble Teaching Hospital A. Michallon, Grenoble cedex 09, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diagmicrobio.2007.03.003DOI Listing
August 2007

Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.

Vaccine 2007 May 9;25(21):4301-11. Epub 2007 Mar 9.

CNRS UMR 5163 - Université Joseph Fourier, UFR de Biologie, Institut Jean Roget, Campus Santé, Domaine de la Merci. BP 170, 38042 Grenoble cedex 09, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2007.02.057DOI Listing
May 2007

Amastin peptide-binding antibodies as biomarkers of active human visceral leishmaniasis.

Clin Vaccine Immunol 2006 Oct;13(10):1104-10

Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, 69 Pasteur Ave., Tehran 13164, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/CVI.00188-06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1595312PMC
October 2006

Leishmaniasis vaccine candidates for development: a global overview.

Indian J Med Res 2006 Mar;123(3):423-38

Center for Research & Training in Skin Disease & Leprosy, Tehran University of Medical Sciences, Tehran, Iran.

View Article

Download full-text PDF

Source
March 2006

Murine cytokine patterns following rubella vaccination.

Iran J Allergy Asthma Immunol 2003 Jun;2(2):89-93

Department of Immunology, Tarbiatt Modarres University, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/02.02/ijaai.8993DOI Listing
June 2003